Revenue grew from $318.6M to $393.1M over the ten quarters while operating margin fell from 15.4% in 2025Q2 to 7.2% in 2026Q3, suggesting rising operating costs are eroding the stable 67.4% gross margin.
LivaNova PLC (LIVN) annual income statement — 30-year revenue, gross profit & net income history
| Metric | TTM | Dec'25 | Dec'24 | Dec'23 | Dec'22 | Dec'21 | Dec'20 | Dec'19 | Dec'18 | Dec'17 | Dec'16 | Apr'15 | Apr'14 | Apr'13 | Apr'12 | Apr'11 | Apr'10 | Apr'09 | Apr'08 | Apr'07 | Apr'06 | Apr'05 | Apr'04 | Apr'03 | Apr'02 | Jun'00 | Jun'99 | Jun'98 | Jun'97 | Jun'96 | Jun'95 |
|---|
| Sales/Revenue | 1.51B | 1.39B | 1.25B | 1.15B | 1.02B | 1.04B | 934.24M | 1.08B | 1.11B | 1.01B | 1.21B | 291.56M | 282.01M | 254.32M | 218.5M | 190.46M | 167.78M | 143.6M | 121.23M | 130.97M | 123.44M | 103.44M | 110.72M | 104.47M | 70.11M | 47.89M | 29.9M | 14.9M | 1.4M | 1.4M | 1M |
| Revenue Growth % | 11.7% | 10.74% | 8.66% | 12.89% | -1.31% | 10.82% | -13.83% | -2.06% | 9.35% | -16.61% | 316.35% | 3.38% | 10.89% | 16.39% | 14.72% | 13.52% | 16.83% | 18.45% | -7.44% | 6.1% | 19.33% | -6.57% | 5.99% | 49% | 46.4% | 60.16% | 100.67% | 964.29% | 0% | 40% | 150% |
| Cost of Goods Sold | 483.49M | 448.2M | 382.56M | 382.3M | 314.58M | 329.37M | 339.48M | 360.37M | 372.5M | 360.7M | 509.5M | 27.31M | 27.35M | 21.91M | 19.66M | 23.02M | 20.91M | 20.04M | 21.09M | 18.26M | 15.82M | 15.58M | 16.3M | 16.07M | 13.62M | 10.38M | 6.2M | 3.2M | 100K | 200K | 0 |
| COGS % of Revenue | - | 32.29% | 30.52% | 33.14% | 30.79% | 31.81% | 36.34% | 33.24% | 33.65% | 35.63% | 41.97% | 9.37% | 9.7% | 8.61% | 9% | 12.09% | 12.46% | 13.96% | 17.4% | 13.94% | 12.82% | 15.06% | 14.72% | 15.38% | 19.42% | 21.68% | 20.74% | 21.48% | 7.14% | 14.29% | - |
| Gross Profit | 1.02B | 939.9M | 870.87M | 771.25M | 707.23M | 705.99M | 594.76M | 723.8M | 734.5M | 651.6M | 704.4M | 264.25M | 254.66M | 232.41M | 198.85M | 167.44M | 146.87M | 123.56M | 100.14M | 112.71M | 107.62M | 87.87M | 94.43M | 88.4M | 56.49M | 37.5M | 23.7M | 11.7M | 1.3M | 1.2M | 1M |
| Gross Margin % | 67.91% | 67.71% | 69.48% | 66.86% | 69.21% | 68.19% | 63.66% | 66.76% | 66.35% | 64.37% | 58.03% | 90.63% | 90.3% | 91.39% | 91% | 87.91% | 87.54% | 86.04% | 82.6% | 86.06% | 87.18% | 84.94% | 85.28% | 84.62% | 80.58% | 78.32% | 79.26% | 78.52% | 92.86% | 85.71% | 100% |
| Gross Profit Growth % | - | 7.93% | 12.92% | 9.05% | 0.17% | 18.7% | -17.83% | -1.46% | 12.72% | -7.5% | 166.57% | 3.77% | 9.57% | 16.88% | 18.75% | 14.01% | 18.86% | 23.39% | -11.15% | 4.73% | 22.48% | -6.95% | 6.82% | 56.48% | 50.63% | 58.25% | 102.56% | 800% | 8.33% | 20% | 66.67% |
| Operating Expenses | 850.62M | 740.5M | 741.82M | 839.75M | 783.98M | 706.78M | 868.66M | 895.36M | 648.2M | 523.4M | 637.2M | 166.9M | 167.2M | 154.07M | 137.9M | 118.26M | 110.01M | 104.57M | 108.37M | 162.24M | 166.85M | 100.77M | 87.73M | 83.72M | 83.71M | 42.76M | 37.8M | 27.9M | 12.7M | 11.6M | 8.9M |
| OpEx % of Revenue | - | 53.35% | 59.18% | 72.8% | 76.72% | 68.26% | 92.98% | 82.58% | 58.55% | 51.7% | 52.49% | 57.25% | 59.29% | 60.58% | 63.11% | 62.09% | 65.57% | 72.82% | 89.39% | 123.87% | 135.17% | 97.42% | 79.24% | 80.14% | 119.39% | 89.28% | 126.42% | 187.25% | 907.14% | 828.57% | 890% |
| Selling, General & Admin | 599.93M | 548.8M | 526.26M | 518.13M | 469.24M | 471.9M | 0 | 0 | 465M | 380.6M | 469.2M | 123.62M | 120.64M | 112.52M | 102.57M | 89.65M | 87.94M | 84.84M | 85.94M | 134.14M | 137.31M | 81.43M | 70.6M | 65.84M | 59.19M | 33.27M | 29.6M | 19.8M | 5.9M | 3.4M | 8.6M |
| SG&A % of Revenue | - | 39.54% | 41.99% | 44.92% | 45.92% | 45.58% | - | - | 42.01% | 37.6% | 38.65% | 42.4% | 42.78% | 44.24% | 46.94% | 47.07% | 52.42% | 59.08% | 70.89% | 102.42% | 111.23% | 78.72% | 63.76% | 63.03% | 84.42% | 69.47% | 99% | 132.89% | 421.43% | 242.86% | 860% |
| Research & Development | 202.57M | 185.8M | 182.51M | 193.82M | 155.81M | 183.41M | 152.9M | 197.15M | 146M | 109.7M | 122.5M | 43.28M | 46.56M | 41.55M | 35.33M | 28.6M | 22.06M | 19.73M | 22.42M | 28.09M | 29.54M | 19.34M | 17.13M | 17.87M | 24.52M | 8.04M | 6.7M | 7.4M | 6.5M | 8M | 0 |
| R&D % of Revenue | - | 13.39% | 14.56% | 16.8% | 15.25% | 17.71% | 16.37% | 18.18% | 13.19% | 10.84% | 10.09% | 14.85% | 16.51% | 16.34% | 16.17% | 15.02% | 13.15% | 13.74% | 18.49% | 21.45% | 23.93% | 18.7% | 15.47% | 17.11% | 34.97% | 16.78% | 22.41% | 49.66% | 464.29% | 571.43% | - |
| Other Operating Expenses | 3M | 5.9M | 33.04M | 127.8M | 158.93M | 51.46M | 715.76M | 698.21M | 37.19M | 33.14M | 45.51M | 642.36K | -295.27K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 600 | 1.45M | 1.5M | 700K | 300K | 200K | 300K |
| Operating Income | 172.7M | 199.4M | 129.05M | -68.5M | -76.75M | -784K | -273.9M | -171.55M | -248.1M | 95.7M | -27.6M | 88.65M | 80.01M | 78.35M | 60.94M | 49.19M | 36.86M | 18.99M | -8.23M | -49.53M | -59.23M | -12.91M | 6.7M | 4.68M | -27.21M | -5.25M | -14.1M | -16.2M | -11.4M | -10.4M | -7.9M |
| Operating Margin % | 11.46% | 14.37% | 10.3% | -5.94% | -7.51% | -0.08% | -29.32% | -15.82% | -22.41% | 9.45% | -2.27% | 30.41% | 28.37% | 30.81% | 27.89% | 25.83% | 21.97% | 13.22% | -6.79% | -37.82% | -47.98% | -12.48% | 6.05% | 4.48% | -38.81% | -10.97% | -47.16% | -108.72% | -814.29% | -742.86% | -790% |
| Operating Income Growth % | - | 54.51% | 288.4% | 10.75% | -9689.8% | 99.71% | -59.66% | 30.85% | -359.25% | 446.74% | -131.13% | 10.8% | 2.13% | 28.56% | 23.9% | 33.44% | 94.12% | 330.77% | 83.39% | 16.39% | -358.98% | -292.76% | 42.95% | 117.21% | -418.23% | 62.76% | 12.96% | -42.11% | -9.62% | -31.65% | -21.54% |
| EBITDA | 247.6M | 241.4M | 180.19M | -7.64M | -18.96M | 67.2M | -192.58M | -88.56M | -178.16M | 165.9M | 57.76M | 95.91M | 85.61M | 82.98M | 65.67M | 51.93M | 39.09M | 21.17M | -4.27M | -45.04M | -54.74M | -8.92M | 11.61M | 9.8M | -22.92M | -3.8M | -12.6M | -15.5M | -11.1M | -10.2M | -7.6M |
| EBITDA Margin % | 16.43% | 17.39% | 14.38% | -0.66% | -1.86% | 6.49% | -20.61% | -8.17% | -16.09% | 16.39% | 4.76% | 32.89% | 30.36% | 32.63% | 30.06% | 27.26% | 23.3% | 14.74% | -3.52% | -34.39% | -44.35% | -8.62% | 10.49% | 9.38% | -32.69% | -7.94% | -42.14% | -104.03% | -792.86% | -728.57% | -760% |
| EBITDA Growth % | -1.48% | 33.97% | 2457.96% | 59.69% | -128.21% | 134.9% | -117.44% | 50.29% | -207.39% | 187.2% | -39.77% | 12.02% | 3.17% | 26.36% | 26.47% | 32.83% | 84.65% | 595.85% | 90.52% | 17.73% | -513.83% | -176.8% | 18.45% | 142.77% | -502.93% | 69.83% | 18.71% | -39.64% | -8.82% | -34.21% | -22.58% |
| D&A (Non-Cash Add-back) | 48.5M | 42M | 51.14M | 60.86M | 57.8M | 67.99M | 81.32M | 82.99M | 69.94M | 70.2M | 85.36M | 7.25M | 5.6M | 4.64M | 4.73M | 2.74M | 2.23M | 2.18M | 3.96M | 4.49M | 4.49M | 3.99M | 4.92M | 5.12M | 4.29M | 1.45M | 1.5M | 700K | 300K | 200K | 300K |
| EBIT | 162.87M | -171.5M | 151.38M | -22.37M | -26.89M | -74.32M | -60.99M | 48.49M | -237.62M | 128.94M | 35.82M | -56.66M | 89.31M | 79.9M | 75.39M | 60.72M | 49.06M | 39.92M | 30.84M | -8.23M | -49.53M | -59.23M | -19.3M | 4.55M | 4.68M | -5.25M | -5.25M | -14.1M | -16.2M | -11.4M | -10.4M |
| Net Interest Income | -33.28M | -30.3M | -32.99M | -36.84M | -43.55M | -49.72M | -40.71M | -14.29M | -8.98M | -6.48M | -8.92M | 0 | 163K | 162K | -35K | 29.39K | -135.68K | -1.34M | -2.16M | -1.97M | -1.26M | 192.99K | 628.22K | -95.78K | 998.58K | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Income | 9.99M | 18.98M | 30.07M | 22.01M | 4.7M | 435K | 131K | 803K | 847K | 1.32M | 1.7M | 0 | 182.27K | 182K | 84K | 326.12K | 92.6K | 1.24M | 3.84M | 4.65M | 3.21M | 1.07M | 469.92K | 469.92K | 1.26M | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 43.28M | 49.29M | 63.07M | 58.85M | 48.25M | 50.15M | 40.84M | 15.09M | 9.82M | 7.8M | 10.62M | 162.89K | 20.05K | 20K | 119K | 296.73K | 1.43M | 3.39M | 5.82M | 5.91M | 3.02M | 444.27K | 565.7K | 565.7K | 266.27K | 44.89K | 0 | 0 | 0 | 0 | 0 |
| Other Income/Expense | -53.12M | -420.2M | -40.74M | -12.83M | 1.56M | -123.84M | -74.39M | 43.92M | 625K | 24.65M | -66.45M | -130.98M | 642K | -133K | -3.07M | -521.42K | -522.71K | 1.63M | 8.46M | -2.37M | -1.57M | 262.45K | 712.95K | -1.85M | 93.69K | -44.89K | 5.25M | 2M | 5M | 1.3M | 3.2M |
| Pretax Income | 119.59M | -220.8M | 88.31M | -81.33M | -75.19M | -124.62M | -348.29M | -127.63M | -247.4M | 121.1M | -33M | 89.29M | 79.88M | 75.27M | 60.42M | 48.66M | 38.49M | 27.45M | -10.6M | -51.1M | -58.97M | -12.19M | 6.99M | 5.31M | -27.12M | -5.3M | -14M | -14.2M | -11.2M | -10.1M | -7.2M |
| Pretax Margin % | 7.94% | -15.91% | 7.05% | -7.05% | -7.36% | -12.04% | -37.28% | -11.77% | -22.35% | 11.96% | -2.72% | 30.63% | 28.32% | 29.6% | 27.65% | 25.55% | 22.94% | 19.12% | -8.74% | -39.02% | -47.77% | -11.79% | 6.31% | 5.09% | -38.68% | -11.06% | -46.82% | -95.3% | -800% | -721.43% | -720% |
| Income Tax | -76.67M | 21.6M | 25.06M | -98.88M | 11.05M | 11.2M | -960K | -30.37M | -69.63M | 49.95M | 5.11M | 31.45M | 31.45M | 24.99M | 28.92M | 24.34M | 1.94M | -39.96M | 729.44K | -264.84K | 78.78K | 99.27K | 26.11K | 230.79K | 129.56K | -2.15M | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | -64.11% | -9.78% | 28.38% | 121.57% | -14.7% | -8.99% | 0.28% | 23.8% | 28.14% | 41.25% | -15.49% | 35.22% | 39.37% | 33.2% | 47.86% | 50.02% | 5.04% | -145.57% | -6.88% | 0.52% | -0.13% | -0.81% | 0.37% | 4.34% | -0.48% | 40.65% | 0% | 0% | 0% | 0% | 0% |
| Net Income | 196.08M | -242.5M | 63.23M | 17.55M | -86.25M | -135.82M | -348.82M | -157.64M | -189.4M | -25.1M | -62.8M | 57.85M | 54.89M | 46.36M | 36.08M | 46.73M | 78.45M | 26.72M | -10.33M | -51.18M | -59.07M | -12.22M | 6.76M | 5.18M | -26.12M | -3.05M | -12.5M | -14.2M | -11.2M | -10.1M | -7.2M |
| Net Margin % | 13.01% | -17.47% | 5.04% | 1.52% | -8.44% | -13.12% | -37.34% | -14.54% | -17.11% | -2.48% | -5.17% | 19.84% | 19.46% | 18.23% | 16.51% | 24.53% | 46.76% | 18.61% | -8.52% | -39.08% | -47.85% | -11.81% | 6.11% | 4.96% | -37.25% | -6.38% | -41.81% | -95.3% | -800% | -721.43% | -720% |
| Net Income Growth % | 190.16% | -483.5% | 260.39% | 120.34% | 36.5% | 61.06% | -121.28% | 16.77% | -654.58% | 60.03% | -208.56% | 5.39% | 18.41% | 28.49% | -22.79% | -40.44% | 193.59% | 358.55% | 79.81% | 13.36% | -383.45% | -280.76% | 30.37% | 119.85% | -755.48% | 75.57% | 11.97% | -26.79% | -10.89% | -40.28% | -22.03% |
| Net Income (Continuing) | 196.16M | -242.5M | 63.25M | 17.55M | -86.25M | -135.82M | -347.33M | -158M | -177.82M | 71.18M | 20.55M | -22.08M | 57.85M | 54.89M | 46.36M | 36.08M | 46.73M | 78.45M | 26.72M | -10.33M | -51.18M | -59.07M | -18.61M | 4.62M | 5.18M | -3.05M | -3.93M | -12.5M | -14.2M | -11.2M | -10.1M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | -1.49M | 365K | 0 | -79.55M | -64.66M | -22.34M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | 3.42 | -4.45 | 1.16 | 0.32 | -1.61 | -2.68 | -7.06 | -3.22 | -3.91 | -0.52 | -1.28 | 2.17 | 2.00 | 1.66 | 1.27 | 1.63 | 2.73 | 0.97 | -0.39 | -2.01 | -2.37 | -0.51 | 0.26 | 0.24 | -1.21 | -0.17 | -0.71 | -0.88 | -0.93 | -1.06 | -0.79 |
| EPS Growth % | 187.5% | -483.62% | 262.5% | 119.88% | 39.93% | 62.04% | -119.25% | 17.65% | -651.92% | 59.38% | -158.99% | 8.5% | 20.48% | 30.71% | -22.09% | -40.29% | 181.44% | 348.72% | 80.6% | 15.19% | -364.71% | -296.15% | 8.33% | 119.83% | -611.76% | 76.06% | 19.32% | 5.38% | 12.26% | -34.18% | -19.7% |
| EPS (Basic) | - | -4.45 | 1.17 | 0.33 | -1.61 | -2.68 | -7.06 | -3.22 | -3.91 | -0.52 | -1.29 | 2.19 | 2.02 | 1.68 | 1.30 | 1.67 | 2.83 | 1.00 | -0.39 | -2.01 | -2.37 | -0.51 | 0.29 | 0.24 | -1.21 | -0.17 | -0.71 | -0.88 | -0.93 | -1.06 | -0.79 |
| Diluted Shares Outstanding | 57.4M | 54.5M | 54.57M | 54.21M | 53.5M | 50.63M | 48.59M | 48.35M | 48.5M | 48.5M | 48.9M | 26.63M | 27.47M | 28.01M | 28.31M | 28.61M | 28.7M | 27.54M | 26.5M | 25.51M | 24.92M | 24.04M | 25.66M | 22.03M | 21.66M | 18.04M | 17.5M | 16.1M | 12.04M | 9.51M | 9.11M |
| Basic Shares Outstanding | 55.1M | 54.5M | 54.24M | 53.9M | 53.5M | 50.63M | 48.59M | 48.35M | 48.5M | 48.2M | 48.86M | 26.39M | 27.14M | 27.6M | 27.83M | 28.05M | 27.7M | 26.63M | 26.5M | 25.51M | 24.92M | 24.04M | 23.09M | 22.03M | 21.66M | 18.04M | 17.5M | 16.1M | 12.04M | 9.51M | 9.11M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Quick answers to the most common questions about buying LIVN stock.
For fiscal year 2025, LivaNova PLC (LIVN) reported total revenue of $1.39B. This represents a 138710.0% increase compared to $1.0M in 1995.
LivaNova PLC (LIVN) reported a net loss of $242.5M for the fiscal year ending 2025.
LivaNova PLC (LIVN) reported an operating income of $199.4M, resulting in an operating profit margin of 14.4%. This margin reflects the operational efficiency of the business before interest and taxes.
LivaNova PLC (LIVN) generated $939.9M in gross profit for the year, representing a gross profit margin of 67.7%. This demonstrates the company's core pricing power and production efficiency.
Key Metrics
Top Statement Risk
Non-operating charges eroding earnings
Metrics are mathematically derived from official filings.
Mid-Single-Digit Revenue Growth Persisting
Based on LivaNova's reported quarterly figures, revenue rose from $318.6M in 2024Q2 to $393.1M in 2026Q3, with year-over-year growth running between roughly 5% and 11% across recent quarters, suggesting steady rather than accelerating expansion.
The most recent quarters show growth in the 9.9% to 10.8% range, a modest improvement from the single-digit prints seen in 2024 and early 2025, which may indicate Cardiopulmonary and Neuromodulation demand is firming. Investors should monitor whether this pace is sustained without reliance on the Q1 2025 distortion, since the reported revenue series does not disclose volume versus pricing contributions needed to judge durability.
Gross Margin Holding Near Two-Thirds
Reported gross margins have oscillated between 66.4% and 70.8% over the ten-quarter window, with the latest 2026Q3 print at 67.4%, which points to a stable premium pricing structure in implantable and disposable products.
The consistency of gross margin across quarters suggests limited erosion from input cost or pricing pressure, consistent with specialized implantable technology commanding durable pricing. Because the data does not separate segment-level margins, it is unclear how much of the blended figure is carried by high-margin VNS implants versus lower-margin capital equipment, which warrants further investigation.
Operating Margin Compressing Despite Revenue Gains
Operating margin declined from 15.4% in 2025Q2 to 7.2% in 2026Q3 even as revenue grew, based on reported figures, indicating operating costs are expanding faster than the gross profit base.
SG&A rose from about $133.7M in 2025Q1 to $154.9M in 2026Q3, absorbing much of the gross profit gains and implying negative operating leverage over the period. This pattern may reflect commercial investment or cost inflation, but without disclosure on the drivers of SG&A growth, investors should treat the deterioration as a signal to monitor rather than a settled conclusion.
Net Income Diverging From Operating Results
Reported net income swings sharply, including a $327.3M loss in 2025Q1 and a $108.6M gain in 2026Q2, while operating income remained comparatively steady, suggesting large non-operating items are driving bottom-line volatility.
The gap between operating income and net income implies substantial non-operating charges or gains that are not explained in the supplied data, and these appear to dominate reported EPS. Stock-based compensation of $7.8M to $16.9M per quarter is modest relative to these swings, so it does not appear to be the primary explanation, leaving the reconciliation between GAAP and operating earnings as a key diligence item.
Recurring Charges May Mask Core Weakness
The steady erosion from a 15.4% operating margin in 2025Q2 to 7.2% in 2026Q3, combined with a reported trailing net margin of -17.5%, may indicate that headline earnings beats overstate the underlying profitability trend.
A bear case would argue that recurring restructuring-type costs and legacy litigation drag are being treated as non-recurring, which could make adjusted metrics look better than the reported economics. The strongest challenge is that the Q3 2026 EPS beat is not matched by a sustained margin recovery, so forward estimates built on the beat may prove optimistic if SG&A growth continues to outpace gross profit.